May 13 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] said its consolidated net profit declined to 4.1 million euro ($4.3 million) in the first quarter of 2022 from 4.8 million euro in the same period of last year.
Consolidated net sales revenue went up by an annual 17.6% to 125.7 million euro in the three-month period through March 2022, Salus said in a filing with the Ljubljana Stock Exchange on Thursday.
The company's operating profit increased to 14.7 million euro from 14.1 million euro in January-March 2021, while EBITDA totalled 6.3 million euro, the same as in the like period of last year.
Ljubljana-based Salus is one of Slovenia's leading wholesalers of pharmaceutical and medical products.
($ = 0.9468 euro)